ProfileGDS4718 / 224572_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 89% 92% 91% 89% 93% 95% 87% 89% 90% 87% 89% 92% 95% 90% 88% 92% 93% 95% 94% 88% 89% 87% 89% 88% 94% 91% 94% 89% 95% 94% 94% 89% 86% 94% 94% 93% 91% 91% 91% 89% 93% 93% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5158285
GSM549102patient 115, normal, homogenized [OPG study]9.0338989
GSM549104patient 119, normal, homogenized [OPG study]9.6340692
GSM549108patient 138, normal, homogenized [OPG study]9.2868691
GSM549119patient 077, normal, homogenized [OPG study]9.1044989
GSM549133patient 032, cancer, homogenized [OPG study]9.8490393
GSM549139patient 042, cancer, homogenized [OPG study]10.063495
GSM549099patient 107, normal, homogenized [OPG study]8.698787
GSM549109patient 139, normal, homogenized [OPG study]9.0910889
GSM549110patient 046, normal, homogenized [OPG study]9.1834690
GSM549114patient 063, normal, homogenized [OPG study]8.9373387
GSM549122patient 082, normal, homogenized [OPG study]8.986889
GSM549134patient 033, cancer, homogenized [OPG study]9.6436292
GSM549136patient 036, cancer, homogenized [OPG study]10.171495
GSM549140patient 044, cancer, homogenized [OPG study]9.305690
GSM549111patient 047, normal, homogenized [OPG study]8.9990988
GSM549113patient 057, normal, homogenized [OPG study]9.7897392
GSM549132patient 031, cancer, homogenized [OPG study]9.6095493
GSM549137patient 038, cancer, homogenized [OPG study]10.036295
GSM549142patient 047, cancer, homogenized [OPG study]9.3857694
GSM549100patient 110, normal, homogenized [OPG study]8.8888388
GSM549107patient 135, normal, homogenized [OPG study]9.048189
GSM549115patient 068, normal, homogenized [OPG study]8.9729387
GSM549116patient 072, normal, homogenized [OPG study]9.1284389
GSM549120patient 078, normal, homogenized [OPG study]8.8694188
GSM549131patient 030, cancer, homogenized [OPG study]9.9412194
GSM549118patient 074, normal, homogenized [OPG study]9.5076591
GSM549129patient 027, cancer, homogenized [OPG study]9.8426594
GSM549123patient 088, normal, homogenized [OPG study]9.109389
GSM549124patient 006, cancer, homogenized [OPG study]9.9703695
GSM549126patient 015, cancer, homogenized [OPG study]9.8604594
GSM549128patient 025, cancer, homogenized [OPG study]9.9472994
GSM549103patient 117, normal, homogenized [OPG study]8.9555289
GSM549117patient 073, normal, homogenized [OPG study]8.6703386
GSM549138patient 041, cancer, homogenized [OPG study]10.03794
GSM549141patient 045, cancer, homogenized [OPG study]10.081794
GSM549130patient 028, cancer, homogenized [OPG study]9.5807493
GSM549101patient 111, normal, homogenized [OPG study]9.2574291
GSM549105patient 128, normal, homogenized [OPG study]9.2782291
GSM549106patient 134, normal, homogenized [OPG study]9.5491591
GSM549112patient 048, normal, homogenized [OPG study]9.1723589
GSM549125patient 011, cancer, homogenized [OPG study]9.7405193
GSM549127patient 024, cancer, homogenized [OPG study]9.7129393
GSM549135patient 035, cancer, homogenized [OPG study]10.420296